U.S. preventive services task force criteria for diabetes screening: Time to revisit the evidence?

American Journal of Preventive Medicine

Volumn 45, Issue 2, 2013, Pages 246-247

  Aroda, Vanita R ^a,b   Fonseca, Vivian A ^c  

^a MEDSTAR RESEARCH INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DYSGLYCEMIA; FOLLOW UP; HEALTH CARE POLICY; HUMAN; HYPERLIPIDEMIA; IMPAIRED GLUCOSE TOLERANCE; NOTE; PREVENTIVE HEALTH SERVICE; SCREENING; SMOKING; UNITED KINGDOM; UNITED STATES;

ADVISORY COMMITTEES; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MASS SCREENING; PREVENTIVE HEALTH SERVICES;

EID: 84880307097     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2013.05.001     Document Type: Note

References (20)

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-46.
2. X.R. Pan, G.W. Li, and Y.H. Hu Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study Diabetes Care 20 1997 537 544
3. J. Tuomilehto, J. Lindström, J.G. Eriksson and the Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 2001 1343 1350
4. W.C. Knowler, E. Barrett-Connor, S.E. Fowler the Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
5. A. Ramachandran, C. Snehalatha, S. Mary, B. Mukesh, A.D. Bhaskar, V. Vijay the Indian Diabetes Prevention Programme (IDPP) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) Diabetologia 49 2006 289 297
6. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
7. Casagrande SS, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care 2013 Feb 15 [Epub ahead of print].
8. CDC. www.cdc.gov/diabetes/statistics/complications-national.htm.
9. American Diabetes Association Standards of medical care in diabetes - 2013 Diabetes Care 36 S1 2013 S11 S66
10. S.S. Casagrande, C.C. Cowie, and J.E. Fradkin Utility of the U.S. Preventive Services Task Force criteria for diabetes screening Am J Prev Med 45 2 2013 167 174
11. U.S. Preventive Services Task Force Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med 148 2008 846 854
12. S.J. Griffin, K. Borch-Johnsen, and M.J. Davies Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial Lancet 378 2011 156 167
13. W.C. Knowler, S.E. Fowler, R.F. Hamman the Diabetes Prevention Program Research Group 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study Lancet 374 2009 1677 1686
14. J. Lindström, P. Ilanne-Parikka, M. Peltonen the Finnish Diabetes Prevention Study Group Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study Lancet 368 2006 1673 1679
15. G. Li, P. Zhang, and J. Wang The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study Lancet 371 2008 1783 1789
16. J. Ma, V. Yank, and L. Xiao Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial JAMA Intern Med 173 2013 113 121
17. R.T. Ackermann, E.A. Finch, E. Brizendine, H. Zhou, and D.G. Marrero Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study Am J Prev Med 35 2008 357 363
18. T. Saaristo, L. Moilanen, and E. Korpi-Hyövälti Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D) Diabetes Care 33 2010 2146 2151
19. S. Saha, U.G. Gerdtham, and P. Johansson Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases Int J Environ Res Public Health 7 2010 3150 3195
20. Diabetes Prevention Program Research Group The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS Diabetes Care 35 2012 723 730 Kidney Diseases